Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
OPERATING ACTIVITIES:
Net income	$ 5,606	$ 4,617
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,940	3,483
Deferred income taxes	74
Stock-based compensation expense	2,722	2,472
Change in provision for losses on accounts receivable	(149)	(149)
Loss on disposal of assets	60
Changes in operating assets and liabilities:
Trade receivables	(567)	4,748
Inventories	25,487	27,901
Other current assets	(2,818)	(2,622)
Other assets	(7,623)
Accounts payable - trade	(3,039)	(6,311)
Accrued liabilities	1,561	(3,430)
Other long-term liabilities	107	(247)
Net cash provided by operating activities	24,361	30,462
INVESTING ACTIVITIES:
Capital expenditures	(4,361)	(3,597)
Net cash (used in) investing activities	(4,361)	(3,597)
FINANCING ACTIVITIES:
Dividends paid	(2,446)	(3,241)
Treasury stock purchases	(1,660)	(2,968)
Proceeds from line of credit	270,421	254,482
Payments on line of credit	(284,510)	(274,494)
Proceeds from issuance of common stock	88
Shares withheld for tax payments on vested restricted shares	(688)	(419)
Net cash (used in) financing activities	(18,795)	(26,640)
Increase in cash and cash equivalents	1,205	225
Cash and cash equivalents at beginning of the period	3,365	2,184
Cash and cash equivalents at end of the period	4,570	2,409
SUPPLEMENTAL INFORMATION
Interest paid	1,470	1,079
Cash paid for income taxes, net	3,273	2,911
Capital expenditures in accounts payable	$ 260	$ 140